In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
The program itself is $199/month, with a minimum 3 month commitment
Oral semaglutide (aka brand-name Rybelsus) can be stored at room temperature
Ramos-LeviAMRubio-HerreraMAMata-MartnPPrez-FerreNMarcuelloCSnchez-PernauteAet alMixed meal tolerance test versus continuous glucose monitoring for an effective diagnosis of persistent post-bariatric hypoglycemia
Each package will state the dosage and how to use it
Ozempic: "Ozempic - Semaglutide." Accessed on December 5, 2023, at "GLP-1 Receptor Agonists and Their Evolving Role in the Management of Obesity." National Library of Medicine